InsidersTradesSigma
Track the 바이오플러스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오플러스 has recorded 1 insider filings. Market capitalisation: €202.2bn. The latest transaction was filed on 2 April 2026 (Purchase). Among the most active insiders: 정현규. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
BioPlus是一家在XKRX上市的医疗保健和制药公司。它专注于生物制药产品的开发。